Universal Corporation reported results for the quarter ended September 30, 2026. Sales fell 18% to $621.8 million, and diluted earnings per share were $0.50 versus $1.36 a year earlier, as tobacco shipments were delayed by the market cycle. Management said shipments are forecast to be heavily weighted to the second half of fiscal 2027.
Quarterly sales of $621.8 million, down 18% from $754.2 million; operating income of $42.6 million, down 37%
Diluted EPS of $0.50 versus $1.36; adjusted diluted EPS (non-GAAP) of $0.39 versus $1.36
Uncommitted tobacco inventory was 19% at September 30, 2026, within the company's target range
Total debt rose to $1.20 billion and net debt (non-GAAP) to $1.15 billion, up $82.3 million from a year earlier
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Universal Corporation's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2026
$2.89B
-1.3%
$1.30
-65.6%
1.1%
FY2025
$2.92B
+7.4%
$3.78
-20.9%
3.3%
FY2024
$2.72B
+6.7%
$4.78
-3.8%
4.4%
FY2023
$2.55B
+21.9%
$4.97
+43.2%
4.9%
FY2022
$2.09B
+6.4%
$3.47
-1.7%
4.1%
Frequently asked questions
When is Universal's next earnings date?
Universal has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Universal earn last quarter?
For the quarter ended Sep 2026, Universal reported diluted EPS of $0.50 (-63.2% year over year) on revenue of $617.37M (-17.6%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.